SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors weigh significant gains driven by structural AI infrastructure demand against market volatility and shifting macroeconomic expectations following Federal Reserve commentary. While the community actively debates whether the current semiconductor rally represents a sustainable long-term shift or an overextended bubble, sentiment remains sharply divided between bulls highlighting data center momentum and bears emphasizing valuation concerns.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is experiencing significant momentum driven by growing commercial validation through partnerships like Volvo and FedEx, alongside aggressive volume and short-covering activity. The community is actively discussing the company's potential as a long-term leader in autonomous trucking, focusing on scaling infrastructure and overcoming industry-wide labor challenges.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing intense volatility as investors weigh conflicting reports surrounding peace talks in the Strait of Hormuz, with community sentiment deeply polarized between bulls betting on continued AI-driven momentum and bears anticipating a geopolitical-triggered correction. Traders are actively debating whether recent diplomatic headlines are a temporary market manipulation tool or a precursor to sustained economic instability.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is capturing investor attention as the market shifts focus toward the future of real-world AI and autonomous transportation, though community sentiment remains divided between long-term optimism for eVTOL technology and frustration over the company's lack of recent technical milestones like piloted transition flights. Discussions are currently dominated by debates over institutional activity, including recent adjustments to holdings by major funds, and the company's progress toward regulatory certification ahead of high-profile global events.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing a massive parabolic rally fueled by severe NAND flash and SSD supply constraints, with community sentiment deeply polarized between retail investors chasing the momentum and bears warning of an unsustainable AI-driven bubble. Traders are closely monitoring the impact of Apple's recent memory price hikes and upcoming Micron earnings, as the community debates whether the stock represents a structural growth story or a historic speculative mania.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the community debates the delayed 80th clinical event in its pivotal REGAL trial, with bulls interpreting the extended duration as a sign of efficacy and bears questioning trial integrity. Investors are closely monitoring potential acquisition catalysts and institutional short-interest metrics while speculating on the company's path toward commercialization or a high-premium buyout.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

HIMS is experiencing significant momentum driven by growing optimism over its expansion into the weight-loss peptide market and positive analyst sentiment regarding its telehealth platform. Investors are actively debating the potential for a short squeeze as the stock reclaims key technical levels, though some remain cautious, pointing to historically volatile price patterns and ongoing discussions regarding regulatory hurdles.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant community attention as investors await imminent Phase 3 VELA trial results, which are expected to demonstrate best-in-class efficacy for their lead asset. The community is actively discussing the potential for a major valuation rerating and intensified M&A interest, with many anticipating that positive clinical data will trigger a significant breakout.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are intensely focused on volatile geopolitical headlines surrounding Iran and the Strait of Hormuz, which have triggered rapid, contradictory price swings in futures as traders weigh the credibility of ongoing peace talks. The community is actively debating the sustainability of the current market structure, with many expressing skepticism toward AI-driven valuations and the recurring nature of these headline-fueled price manipulations.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is currently trending due to intense community debate over its perceived overvaluation and the sustainability of the AI-driven sector rally. While bulls point to robust demand for chip hardware as a fundamental catalyst, skeptics are actively highlighting potential headwinds like export controls, geopolitical tensions, and concerns that the sector is becoming a crowded, bubble-like trade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Chewy's Autoship Program Continues to Drive Customer Growth

CHWY's Autoship program drives recurring revenue growth, customer engagement and market share gains, reinforcing long-term momentum.

Chewy Stock Tumbles 45% in 3 Months: What Should Investors Do Now?

CHWY shares plunge 45% in three months as weaker spending and a lower sales outlook pressure growth despite market-share gains.

Is CHWY Stock a Buy After Its Selloff and Lower Revenue View

CHWY's sharp selloff and lower fiscal 2026 revenue outlook put its cheap sales multiple, Autoship strength and demand risks in focus.

CHWY Is Tapping AI and Pet Health to Expand Margins in 2026

Chewy is leaning on pet health, AI and ads to widen fiscal 2026 margins, even as cautious consumers pressure sales and spending trends.

Chewy Stock Outlook Hinges on Autoship and Pet Health Growth

Chewy's stock outlook rests on Autoship durability, pet health expansion and margin gains as cautious consumers pressure 2026 sales expectations.

Central Garden & Pet Company (CENTA) Hit a 52 Week High, Can the Run Continue?

Central Garden (CENTA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Is Alto Ingredients (ALTO) Stock Outpacing Its Consumer Discretionary Peers This Year?

Here is how Alto Ingredients (ALTO) and Central Garden (CENT) have performed compared to their sector so far this year.

Central Garden & Pet Company (CENT) Hit a 52 Week High, Can the Run Continue?

Central Garden (CENT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Why Central Garden (CENT) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Is Central Garden (CENT) Up 2.7% Since Last Earnings Report?

Central Garden (CENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Central Garden & Pet Co. engages in the production and distribution of branded and private label products for the lawn, garden, and pet supplies markets. It operates through the Pet and Garden segments. The Pet segment focuses on dog and cat supplies such as dog treats and chews, toys, pet beds and containment, grooming products, waste management and training pads, supplies for aquatics, small animals, reptiles and pet birds including toys, cages and habitats, bedding, food and supplements, products for equine and livestock, animal and household health and insect control products, live fish, and small animals, as well as outdoor cushions. The Garden segment includes lawn and garden consumables such as grass, vegetable, flower and herb seed, wild bird feed, bird houses and other birding accessories, weed, grass, and other herbicides, insecticide and pesticide products, fertilizers, and live plants. The company was founded by William E. Brown in 1980 and is headquartered in Walnut Creek, CA.

Central Garden & Pet Co.

Central Garden & Pet Q1 Earnings Smashes Estimates, Lifts Stock, But Retail Sentiment Lags

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$1.51	--	--	N/A
Q2 '26	$1.09	$1.29	18.14%	BEAT
Q1 '26	$0.14	$0.21	51.80%	BEAT
Q4 '25	-$0.20	-$0.09	53.89%	BEAT
Q3 '25	$1.43	$1.56	9.31%	BEAT

CENTCentral Garden & Pet Co.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '26

Historical Earnings

Latest CENT News